Literature DB >> 24557543

Relationship between VEGF protein expression and lymph node metastasis in papillary thyroid carcinoma among Asians: a meta-analysis.

De-Feng Chang1, Zhong-Qing Xu, Bin Sun.   

Abstract

We carried out the current meta-analysis of relevant cohort studies in an attempt to investigate the relationships between vascular endothelial growth factor (VEGF) protein expression and lymph node (LN) metastasis in papillary thyroid carcinoma (PTC) among Asians. A range of electronic databases were searched, including Web of Science (1945∼2013), the Cochrane Library Database (Issue 12, 2013), MEDLINE (1966∼2013), EMBASE (1980∼2013), CINAHL (1982∼2013), and Chinese Biomedical Database (CBM) (1982~2013) with cross-referencing without language restrictions. Meta-analysis was conducted using the STATA 12.0 software. Crude odds ratio (OR) with their 95 % confidence interval (95 %CI) was calculated. Twelve clinical cohort studies with a total of 1,045 PTC patients were included in our meta-analysis, The results of our meta-analysis revealed that patients with VEGF-positive tumors had a 3.02-fold higher risk of LN metastasis than that of patients with VEGF-negative tumors (OR=3.02, 95 %CI=2.05~4.43, P<0.001). Furthermore, subgroup analysis by country suggested that VEGF-positive expression was associated with an increased risk of LN metastasis in PTC patients among Chinese populations (OR=3.33, 95 %CI=2.30~4.83, P<0.001), but not among Korean, Turkish, and Japanese populations (all P>0.05). Our findings support the view that VEGF protein expression may be correlated with LN metastasis in PTC patients, especially among Chinese populations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24557543     DOI: 10.1007/s13277-014-1725-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  41 in total

1.  Optical aptasensors for the analysis of the vascular endothelial growth factor (VEGF).

Authors:  Ronit Freeman; Julia Girsh; Amily Fang-ju Jou; Ja-an Annie Ho; Thomas Hug; Jens Dernedde; Itamar Willner
Journal:  Anal Chem       Date:  2012-07-05       Impact factor: 6.986

2.  Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation.

Authors:  Daniela Pasquali; Angela Santoro; Pantaleo Bufo; Giovanni Conzo; William J Deery; Andrea Renzullo; Giacomo Accardo; Valentina Sacco; Antonio Bellastella; Giuseppe Pannone
Journal:  Thyroid       Date:  2011-04       Impact factor: 6.568

3.  Menstrual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women.

Authors:  Geoffrey C Kabat; Mimi Y Kim; Jean Wactawski-Wende; Dorothy Lane; Sylvia Wassertheil-Smoller; Thomas E Rohan
Journal:  Cancer Causes Control       Date:  2012-10-23       Impact factor: 2.506

Review 4.  Pathways mediating VEGF-independent tumor angiogenesis.

Authors:  Napoleone Ferrara
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-11       Impact factor: 7.638

5.  The effect of VEGF functionalization of titanium on endothelial cells in vitro.

Authors:  Chye Khoon Poh; Zhilong Shi; Tee Yong Lim; Koon Gee Neoh; Wilson Wang
Journal:  Biomaterials       Date:  2009-12-05       Impact factor: 12.479

6.  Expression of vascular endothelial growth factor family messenger RNA in diseased thyroid tissues.

Authors:  Katsuhiro Tanaka; Junichi Kurebayashi; Hiroshi Sonoo; Takemi Otsuki; Yutaka Yamamoto; Sumiko Ohkubo; Shigeru Yamamoto; Kojiro Shimozuma
Journal:  Surg Today       Date:  2002       Impact factor: 2.549

Review 7.  Role of vascular endothelial growth factor in kidney disease.

Authors:  Kent Doi; Eisei Noiri; Toshiro Fujita
Journal:  Curr Vasc Pharmacol       Date:  2010-01       Impact factor: 2.719

8.  [Clinical significance of HIF-1 alpha,VEGF and VEGF-C expression in papillary thyroid carcinoma].

Authors:  Yaqiu Wang; Qingquan Hua
Journal:  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2007-03

9.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

Authors:  John M L Ebos; Christina R Lee; William Cruz-Munoz; Georg A Bjarnason; James G Christensen; Robert S Kerbel
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

10.  Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma.

Authors:  Ali Salajegheh; Sahar Pakneshan; Atiqur Rahman; Elliot Dolan-Evans; Sheldon Zhang; Esther Kwong; Vinod Gopalan; Chung-Yau Lo; Robert Anthony Smith; Alfred King-Yin Lam
Journal:  Hum Pathol       Date:  2013-07-08       Impact factor: 3.466

View more
  2 in total

1.  Distant dissemination of mixed low-grade astroblastoma-arteriovenous malformation after initial operation: a case report.

Authors:  Kun Yao; Bin Wu; Mei Xi; Zejun Duan; Jiqiang Wang; Xueling Qi
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 2.  Recurrence of differentiated thyroid carcinoma during full TSH suppression: is the tumor now thyroid hormone dependent?

Authors:  Paul J Davis; Aleck Hercbergs; Mary K Luidens; Hung-Yun Lin
Journal:  Horm Cancer       Date:  2014-10-08       Impact factor: 3.869

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.